A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis
Titel:
A phase 2 study of brentuximab vedotin in patients with CD30-positive advanced systemic mastocytosis
Auteur:
Gotlib, Jason Baird, John H. George, Tracy I. Langford, Cheryl Reyes, Isabel Abuel, Justin Perkins, Cecelia Schroeder, Kurt Bose, Prithviraj Verstovsek, Srdan